Solvay Expands US Peroxides Production

Growing demand for hydrogen peroxide has prompted Solvay to announce a capacity expansion at its facility in Longview, Washington, US. Production is expected to rise by about 20% following a "multi-million" dollar investment.

The project will be carried out in two stages. Construction of phase one is scheduled to start later this year with completion due in late 2016. A firm timescale was not divulged for phase two, however Solvay said a second-stage expansion will take place in the near future as market conditions require.

Solvay, the world's largest producer of hydrogen peroxide, said the additional capacity will meet rising demand from pulp and paper producers in the Pacific Northwest and other industrial markets around the US. The expansion will also support internal demand growth for electronic grade peroxide.

Paul Hogan, Solvay's North American senior vice president for peroxides, said: "We have seen tightening market conditions in recent years, conditions that should continue for the near future, and this investment is needed to support our customers' significant growth."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.